ICICI Direct's report on Cadila Healthcare Revenues grew 16.7% YoY to Rs 2459.5 crore mainly on the back of 25.2% YoY growth in the US formulations business to Rs 1003.8 crore (I-direct estimate: Rs 997.4 crore). Domestic formulations grew 10.4% ... Moneycontrol.com, 1 month ago
Opportunities in PCSK9 Inhibitors, CETP Inhibitors, MTTP Inhibitors, ApoB Inhibitors and PPAR Agonists What can be expected from the cholesterol-lowering drugs market? Which areas are going to grow at the fastest rates? This visiongain report ...Fat Pitch Financials, 5 days ago
More from: Town Hall, Town Hall...and 22 other sources
Sharekhan's Top Research Picks After tough market conditions in August and September, the benchmark indices recovered by 1.5-2.0% during October this year. However, volatility sustained within the range of a few hundred points on the Nifty in the ...Moneycontrol.com, 3 weeks ago Sharekhan's top stock picks Moneycontrol.com, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!